Try our Advanced Search for more refined results
March 19, 2020
Hoffmann-La Roche, Inc. et al v. Fresenius Kabi USA, LLC
Case Number:
1:20-cv-00394
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
- Chugai Pharmaceutical Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Fresenius Kabi AG
- Fresenius SE & Co. KGaA
- Genentech Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 20, 2020
Genentech Sues Fresenius Kabi Over Generic Cancer Drug
Genentech Inc. has asked a Delaware federal court to block Fresenius Kabi USA LLC from releasing a generic version of the lung cancer drug Alecensa a decade before the patents expire.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login